[go: up one dir, main page]

CN102133343B - 治疗梅尼埃病的中药制剂 - Google Patents

治疗梅尼埃病的中药制剂 Download PDF

Info

Publication number
CN102133343B
CN102133343B CN2010105202285A CN201010520228A CN102133343B CN 102133343 B CN102133343 B CN 102133343B CN 2010105202285 A CN2010105202285 A CN 2010105202285A CN 201010520228 A CN201010520228 A CN 201010520228A CN 102133343 B CN102133343 B CN 102133343B
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
medicine preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010105202285A
Other languages
English (en)
Other versions
CN102133343A (zh
Inventor
宋爱民
宋紫玲
宋钊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rudong Wenyuan Investment And Development Co ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010105202285A priority Critical patent/CN102133343B/zh
Publication of CN102133343A publication Critical patent/CN102133343A/zh
Application granted granted Critical
Publication of CN102133343B publication Critical patent/CN102133343B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

本发明属于中药制剂领域,特别涉及一种治疗梅尼埃病的中药制剂,其特征在于是由如下重量份数的原料制成:半夏2份、天麻3份、泽泻3份、川芎2份、白芷2份、益母草3份、茯苓3份和葛根4份。本发明是在中医辩证施治的基础上结合长期的临床实践研制而成的,诸药相合具有健脾燥湿、涤痰熄风的功效,治疗梅尼埃病具有疗效确切、见效快、治愈率高、疗程短、无毒副作用、服用方便等优点。

Description

治疗梅尼埃病的中药制剂
技术领域
本发明属于中药制剂领域,特别涉及一种治疗梅尼埃病的中药制剂。
背景技术
梅尼埃病为膜迷路积水所致的疾病,多发于青壮年,临床中常有反复突发旋转性眩晕,睁眼、转头时加剧,闭目、静卧时减轻,伴有恶心、呕吐、面色苍白,耳鸣、耳聋;眩晕可持续几分钟至几小时,甚至几日,而后自然缓解。本病属中医“内耳眩晕”的范畴,主要病机是脾虚痰盛、上扰清窍所致,中医临床中采取健脾燥湿、涤痰熄风的治疗方法,收到了很好的效果。
发明内容
本发明所要解决的技术问题是提供一种具有健脾燥湿、涤痰熄风功效的治疗梅尼埃病的中药制剂,克服了现有治疗梅尼埃病技术易复发、效果慢、副作用大等缺点。
治疗梅尼埃病的中药制剂,其特征在于是由如下重量份数的原料制成:半夏2份、天麻3份、泽泻3份、川芎2份、白芷2份、益母草3份、茯苓3份和葛根4份。
本发明可以制成中药学上可接受的各种制剂,优选丸剂。制作方法为常规的中药制作方法:按重量份数称取上述原料,共轧为细粉,和匀,过80-100目细罗;用冷开水将药粉泛为小丸,晒干或低温干燥;装袋,每袋10克,入盒密封。口服,一次一袋,日服三次,十天为一个疗程。
本发明药物机理如下:
半夏:燥湿化痰、降逆止呕、消痞散结,外用消肿止痛,本品辛温而燥,是温化寒痰之要药,善治脏腑之湿痰。
天麻:息风止痉、平抑肝阳、祛风通络;本品甘润不烈、作用平和,无论寒热虚实皆可应用,本品既息肝风又平肝阳,故为止眩晕之要药。
泽泻:利水渗湿、泻热。
川芎:活血行气、祛风止痛;本品辛温升散,能上行头目祛风止痛治疗头疼头晕,无论风湿、风寒、风热、血虚、血瘀皆可配伍用之,前人有“头疼不离川芎”之说。
白芷:解表散风、通窍止痛、燥湿止带、消肿排脓;本品辛散而燥,善治阳明经风湿之邪而止头额疼痛。
茯苓:利水渗湿、健脾安神。
葛根:解肌退热、透发麻疹、生津止渴、升阳止泻;据文献报道本品有扩张冠脉血管和脑血管增加血流量,尤其增加脑血流量的作用。
益母草:活血调经、利水消肿、清热解毒。
本发明有如下优点:
(1)本发明所使用的中草药符合《中华人民共和国药典》规定,药物安全可靠。
(2)诸药相合具有健脾燥湿、涤痰熄风的功效,治疗梅尼埃病具有疗效确切、见效快、治愈率高、疗程短、无毒副作用、服用方便等优点。
疗效判断:
痊愈:眩晕、恶心、呕吐、面色苍白,耳鸣、耳聋等症状完全消失,全身无阳性体征可查。
好转:症状基本消失,劳累或生气后偶感眩晕,休息后症状自行缓解。
治疗结果:治疗梅尼埃病患者80例,患者服用本发明丸剂,每次一袋,日服三次,十天为一个疗程。经过两个疗程治疗,痊愈72例,占90%,好转8例,占10%,总有效率100%。通过两个疗程治疗观察,病人无任何不良反应,三大常规化验及肝肾功能检测未发现异常现象。
以下列举几个典型病例:
病例1:患者翟某某,女,47岁,因常头晕、耳鸣、恶心呕吐等症两年余,在省立医院诊为梅尼埃病,中西医治疗未能痊愈,劳累过度则病情复发,故于2001年5月宿疾复发就诊我院,口服本发明药物治疗两个疗程痊愈,随访一年无复发。
病例2:患者陈某某,女,40岁,因眩晕、头胀痛、恶心呕吐、纳呆倦怠,诊为梅尼埃病,口服本发明药物治疗2个疗程后痊愈,随访一年无复发。
病例3:患者刘某某,女,37岁,患梅尼埃病,口服本发明药物治疗两个疗程后痊愈。随访一年无复发。
具体实施方式
实施例:丸剂,按重量份数称取原料:半夏2份、天麻3份、泽泻3份、川芎2份、白芷2份、益母草3份、茯苓3份和葛根4份。制备方法:共轧为细粉,和匀,过80-100目细罗;用冷开水将药粉泛为小丸;晒干或低温干燥,装袋,每袋10克,入盒密封。

Claims (2)

1.一种治疗梅尼埃病的中药制剂,其特征在于是由如下重量份数的原料制成:半夏2份、天麻3份、泽泻3份、川芎2份、白芷2份、益母草3份、茯苓3份和葛根4份。
2.根据权利要求1所述的中药制剂,其特征在于为丸剂。
CN2010105202285A 2010-10-27 2010-10-27 治疗梅尼埃病的中药制剂 Expired - Fee Related CN102133343B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105202285A CN102133343B (zh) 2010-10-27 2010-10-27 治疗梅尼埃病的中药制剂

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105202285A CN102133343B (zh) 2010-10-27 2010-10-27 治疗梅尼埃病的中药制剂

Publications (2)

Publication Number Publication Date
CN102133343A CN102133343A (zh) 2011-07-27
CN102133343B true CN102133343B (zh) 2012-02-29

Family

ID=44293356

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105202285A Expired - Fee Related CN102133343B (zh) 2010-10-27 2010-10-27 治疗梅尼埃病的中药制剂

Country Status (1)

Country Link
CN (1) CN102133343B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103190569B (zh) * 2013-04-18 2014-04-02 刘晓伟 一种用于治疗梅尼埃病的中药保健食品

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1616013A (zh) * 2004-09-17 2005-05-18 鲁南制药股份有限公司 一种治疗眩晕的中药组合物及其制备、质量控制方法
CN101167969A (zh) * 2007-09-28 2008-04-30 黄国耀 治疗梅尼埃综合症的中药

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1616013A (zh) * 2004-09-17 2005-05-18 鲁南制药股份有限公司 一种治疗眩晕的中药组合物及其制备、质量控制方法
CN101167969A (zh) * 2007-09-28 2008-04-30 黄国耀 治疗梅尼埃综合症的中药

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张正业等.天麻汤治疗美尼尔氏病46例.《青岛医药卫生》.1997,第29卷(第5期),37-38. *
陆安锠.定眩汤治疗眩晕37例.《中国民间疗法》.2000,第8卷(第1期),28. *

Also Published As

Publication number Publication date
CN102133343A (zh) 2011-07-27

Similar Documents

Publication Publication Date Title
CN103845642A (zh) 一种清热解毒凉血美颜的组合物
CN102125663B (zh) 治疗脑震荡的中药制剂
CN103100039A (zh) 治疗阴虚火旺型失眠的中药丸剂
CN102125678B (zh) 治疗脏躁病的中药制剂
CN102526459B (zh) 一种治疗鼻窦炎的中药组合物及其制备方法
CN102362979A (zh) 一种防治风湿病的药酒
CN101757408A (zh) 一种治疗红斑狼疮的药物及其制备方法
CN103007063B (zh) 一种治疗面瘫的药物组合物及其制备方法
CN103610936B (zh) 一种治疗冠心病的中药制剂及制备方法
CN102670745A (zh) 一种治疗面神经麻痹的中成药
CN102133343B (zh) 治疗梅尼埃病的中药制剂
CN102670882A (zh) 一种内服治疗面神经麻痹的中药制剂
CN102068597B (zh) 治疗更年期综合症的中药制剂
CN101129569A (zh) 一种内服治疗急性鼻窦炎的中药汤剂
CN102406903B (zh) 治疗胃酸过多的中药制剂
CN104547384A (zh) 一种治疗百草枯中毒的口服液及制备方法
CN102406913A (zh) 一种治疗郁证的中药组合物
CN103638259A (zh) 治疗肝郁型月经先后无定期的中药丸剂
CN102125627B (zh) 治疗慢性盆腔炎的中药制剂
CN102670957B (zh) 保健组合物及其制备方法和用途
CN101961474B (zh) 一种治疗胃肠疾病的中药制剂
CN104352707A (zh) 治疗黄褐斑的中药丸剂
CN104771558A (zh) 治疗肾炎的中药组合物及制备方法
CN104825846A (zh) 一种治疗面神经炎的中药组合物
CN104001106A (zh) 治疗病毒性心肌炎后遗症频繁早博的组合中药

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: RUDONG TECHNOLOGY CENTER

Free format text: FORMER OWNER: SONG AIMIN

Effective date: 20131206

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 256100 ZIBO, SHANDONG PROVINCE TO: 226400 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20131206

Address after: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong

Patentee after: Rudong science and Technology Center

Address before: 256100 Yiyuan people's Hospital, Zibo, Shandong, China

Patentee before: Song Aimin

TR01 Transfer of patent right

Effective date of registration: 20200421

Address after: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province

Patentee after: Rudong industrial and commercial information consulting service center

Address before: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong

Patentee before: Rudong science and Technology Center

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20211222

Address after: Fengli town Xinjian West Road, Rudong County, Nantong City, Jiangsu Province 226400

Patentee after: Rudong Wenyuan investment and Development Co.,Ltd.

Address before: 226400 No.10 Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province

Patentee before: Rudong industrial and commercial information consulting service center

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120229